tranexamic acid has been researched along with Abdominal Aortic Aneurysm in 7 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to evaluate tranexamic acid (TA) for the prevention of type II endoleak (EL2) at a high level of evidence by a randomized controlled trial." | 9.51 | Randomized Controlled Trial of Oral Tranexamic Acid Intervention for the Prevention of Type II Endoleak after Endovascular Abdominal Aneurysm Repair. ( Arima, T; Imaeda, Y; Ishibashi, H; Maruyama, Y; Mitsuoka, H; Orimoto, Y, 2022) |
| "The purpose of this study was to evaluate tranexamic acid (TA) for the prevention of type II endoleak (EL2) at a high level of evidence by a randomized controlled trial." | 5.51 | Randomized Controlled Trial of Oral Tranexamic Acid Intervention for the Prevention of Type II Endoleak after Endovascular Abdominal Aneurysm Repair. ( Arima, T; Imaeda, Y; Ishibashi, H; Maruyama, Y; Mitsuoka, H; Orimoto, Y, 2022) |
| " Studies to identify the dosage of TXA that is optimally safe and effective in this application, as well as investigations of the best timing and route (parenteral vs oral) for TXA administration, are warranted." | 5.40 | Effect of antifibrinolytic therapy with tranexamic acid on abdominal aortic aneurysm shrinkage after endovascular repair. ( Aoki, A; Irie, H; Kamihira, S; Mayazaki, N; Sangawa, K; Suezawa, T; Yamamoto, S; Yamaoka, T, 2014) |
| "Chronic disseminated intravascular coagulation (DIC) is a well-known complication of aortic aneurysm." | 5.33 | Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm. ( Arahata, M; Asakura, H; Hayashi, T; Kadohira, Y; Maekawa, M; Minami, S; Morishita, E; Nakao, S; Ontachi, Y; Saito, M; Yamazaki, M, 2005) |
| "To demonstrate feasibility and efficacy of preoperative coil embolization of side branches and postoperative tranexamic acid (TXA) therapy for management of type II endoleak and aneurysmal sac regression after endovascular aortic repair (EVAR)." | 3.85 | Preoperative Coil Embolization of Side Branches and Postoperative Antifibrinolytic Therapy in Endovascular Aneurysm Repair: A Propensity Score Analysis. ( Chikazawa, G; Hiraoka, A; Ishida, A; Sakaguchi, T; Tamura, K; Totsugawa, T; Yoshitaka, H, 2017) |
| " Studies to identify the dosage of TXA that is optimally safe and effective in this application, as well as investigations of the best timing and route (parenteral vs oral) for TXA administration, are warranted." | 1.40 | Effect of antifibrinolytic therapy with tranexamic acid on abdominal aortic aneurysm shrinkage after endovascular repair. ( Aoki, A; Irie, H; Kamihira, S; Mayazaki, N; Sangawa, K; Suezawa, T; Yamamoto, S; Yamaoka, T, 2014) |
| "Treatment with tranexamic acid inhibited plasmin generation and abrogated enhanced AAA progression in pCPB(-/-) mice." | 1.36 | Enhanced abdominal aortic aneurysm formation in thrombin-activatable procarboxypeptidase B-deficient mice. ( Dalman, RL; Du, X; Leung, LL; Morser, J; Myles, T; Nishimura, T; Schultz, G; Sharif, S; Sho, E; Tedesco, MM, 2010) |
| "Chronic disseminated intravascular coagulation (DIC) is a well-known complication of aortic aneurysm." | 1.33 | Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm. ( Arahata, M; Asakura, H; Hayashi, T; Kadohira, Y; Maekawa, M; Minami, S; Morishita, E; Nakao, S; Ontachi, Y; Saito, M; Yamazaki, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Imaeda, Y | 1 |
| Ishibashi, H | 1 |
| Orimoto, Y | 1 |
| Maruyama, Y | 1 |
| Mitsuoka, H | 1 |
| Arima, T | 1 |
| Aoki, A | 1 |
| Suezawa, T | 1 |
| Yamamoto, S | 1 |
| Sangawa, K | 1 |
| Irie, H | 1 |
| Mayazaki, N | 1 |
| Kamihira, S | 1 |
| Yamaoka, T | 1 |
| Uzuka, T | 1 |
| Nakamura, M | 1 |
| Kuroda, Y | 1 |
| Watanabe, N | 1 |
| Moris, D | 1 |
| Hiraoka, A | 1 |
| Chikazawa, G | 1 |
| Ishida, A | 1 |
| Totsugawa, T | 1 |
| Tamura, K | 1 |
| Sakaguchi, T | 1 |
| Yoshitaka, H | 1 |
| Schultz, G | 1 |
| Tedesco, MM | 1 |
| Sho, E | 1 |
| Nishimura, T | 1 |
| Sharif, S | 1 |
| Du, X | 1 |
| Myles, T | 1 |
| Morser, J | 1 |
| Dalman, RL | 1 |
| Leung, LL | 1 |
| Ontachi, Y | 1 |
| Asakura, H | 1 |
| Arahata, M | 1 |
| Kadohira, Y | 1 |
| Maekawa, M | 1 |
| Hayashi, T | 1 |
| Yamazaki, M | 1 |
| Morishita, E | 1 |
| Saito, M | 1 |
| Minami, S | 1 |
| Nakao, S | 1 |
1 trial available for tranexamic acid and Abdominal Aortic Aneurysm
| Article | Year |
|---|---|
Randomized Controlled Trial of Oral Tranexamic Acid Intervention for the Prevention of Type II Endoleak after Endovascular Abdominal Aneurysm Repair.
Topics: Aortic Aneurysm, Abdominal; Blood Vessel Prosthesis Implantation; Endoleak; Endovascular Procedures; | 2022 |
6 other studies available for tranexamic acid and Abdominal Aortic Aneurysm
| Article | Year |
|---|---|
Effect of antifibrinolytic therapy with tranexamic acid on abdominal aortic aneurysm shrinkage after endovascular repair.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aortic Aneurysm, Abdominal; Aortography; Blood Ves | 2014 |
The use of an anti-fibrinolytic agent to reduce endoleak following endovascular repair of multiple aortic aneurysms.
Topics: Aged; Antifibrinolytic Agents; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Endoleak; Endo | 2015 |
eComment: Treating endoleak type 2 and disseminated intravascular coagulopathy after EVAR with tranexamic acid: the efficacy of killing two birds with one stone.
Topics: Antifibrinolytic Agents; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Endoleak; Endovascul | 2015 |
Preoperative Coil Embolization of Side Branches and Postoperative Antifibrinolytic Therapy in Endovascular Aneurysm Repair: A Propensity Score Analysis.
Topics: Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal; Aortography; Blood Vessel Prosthesis Implantati | 2017 |
Enhanced abdominal aortic aneurysm formation in thrombin-activatable procarboxypeptidase B-deficient mice.
Topics: Animals; Antifibrinolytic Agents; Aortic Aneurysm, Abdominal; Aortic Rupture; Apolipoproteins E; Car | 2010 |
Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm.
Topics: Anticoagulants; Antifibrinolytic Agents; Aortic Aneurysm, Abdominal; Chondroitin Sulfates; Dermatan | 2005 |